The effect of N-acetylcysteine on alcohol use during a cannabis cessation trial

Drug and Alcohol Dependence

Volumn 185, Issue , 2018, Pages 17-22

  Squeglia, Lindsay M ^a   Tomko, Rachel L ^a   Baker, Nathaniel L ^a   McClure, Erin A ^a   Book, George A ^a   Gray, Kevin M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alcohol; Cannabis; Marijuana; Medication; N acetylcysteine; Treatment

Indexed keywords

ACETYLCYSTEINE; CANNABIS; PLACEBO;

ADULT; AGE DISTRIBUTION; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BINGE DRINKING; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; CANNABIS ADDICTION; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

ACETYLCYSTEINE; ADOLESCENT; ADULT; ALCOHOL DRINKING; ALCOHOLISM; CANNABIS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85044371702     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2017.12.005     Document Type: Article

References (34)

1. Back, S.E., McCauley, J.L., Korte, K.J., Gros, D.F., Leavitt, V., Gray, K.M., Hamner, M.B., DeSantis, S.M., Malcolm, R., Kalivas, P.W., A double-blind randomized, controlled pilot trial of N-acetylcysteine in Veterans with posttraumatic stress disorder and substance use disorders. J. Clin. Psychiatry 77 (2016), e1439–e1446.
2. Chaloupka, F.J., Laixuthai, A., Do youths substitute alcohol and marijuana? Some econometric evidence. East. Econ. J. 23 (1997), 253–276.
3. Copersino, M.L., Boyd, S.J., Tashkin, D.P., Huestis, M.A., Heishman, S.J., Dermand, J.C., Simmons, M.S., Gorelick, D.A., Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am. J. Addict. 15 (2006), 297–302.
4. Froeliger, B., McConnell, P.A., Stankeviciute, N., McClure, E.A., Kalivas, P.W., Gray, K.M., The effects of N-acetylcysteine on frontostriatal resting-state functional connectivity, withdrawal symptoms and smoking abstinence A double-blind, placebo-controlled fMRI study. Drug Alcohol Depend. 156 (2015), 234–242.
5. Grandjean, E.M., Berthet, P., Ruffmann, R., Leuenberger, P., Efficacy of oral long-term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis of published double-blind, placebo-controlled clinical trials. Clin. Ther. 22 (2000), 209–221.
6. Grant, J.E., Kim, S.W., Odlaug, B.L., N-acetyl cysteine a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol. Psychiatry 62 (2007), 652–657.
7. Grant, J.E., Odlaug, B.L., Kim, S.W., N-acetylcysteine a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch. Gen. Psychiatry 66 (2009), 756–763.
8. Grant, J.E., Chamberlain, S.R., Redden, S.A., Leppink, E.W., Odlaug, B.L., Kim, S.W., N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry 73 (2016), 490–496.
9. Gray, K.M., Watson, N.L., Carpenter, M.J., Larowe, S.D., N-acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am. J. Addict. 19 (2010), 187–189.
10. Gray, K.M., Carpenter, M.J., Baker, N.L., DeSantis, S.M., Kryway, E., Hartwell, K.J., McRae −Clark, A.L., Brady, K.T., A double-blind randomized controlled trial of N-acetylcysteine in cannabis-dependent adolescents. Am. J. Psychiatry 169 (2012), 805–812.
11. Gray, K.M., Sonne, S.C., McClure, E.A., Ghitza, U.E., Matthews, A.G., McRae-Clark, A.L., Carroll, K.M., Potter, J.S., Wiest, K., Mooney, L.J., Hasson, A., Walsh, S.L., Lofwall, M.R., Babalonis, S., Lindbald, R.W., Sparenborg, S., Wahle, A., King, J.S., Baker, N.L., Tomko, R.L., Haynes, L.F., Vandrey, R.G., Levin, F.R., A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults. Drug Alcohol Depend. 177 (2017), 249–257.
12. He, H., Tang, W., Wang, W., Crits-Christoph, P., Structural zeroes and zero-inflated models. Shanghai Arch. Psychiatry 26 (2014), 236–242.
13. Kalivas, P.W., Volkow, N.D., New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol. Psychiatry 16 (2011), 974–986.
14. Kalivas, P.W., The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 10 (2009), 561–572.
15. Knackstedt, L.A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S., Markou, A., Kalivas, P.W., The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol. Psychiatry 65 (2009), 841–845.
16. Koob, G.F., Volkow, N.D., Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatry 3 (2016), 760–773.
17. LaRowe, S.D., Myrick, H., Hedden, S., Mardikian, P., Saladin, M., McRae, A., Brady, K., Kalivas, P.W., Malcolm, R., Is cocaine desire reduced by N-acetylcysteine?. Am. J. Psychiatry 164 (2007), 1115–1117.
18. Lambert, D., Zero-inflated poisson regression: with an application to defects in manufacturing. Technometrics 34 (1992), 1–14.
19. Lebourgeois, S., González-Marín, M.C., Jeanblanc, J., Naassila, M., Vilpoux, C., Effect of N-acetylcysteine on motivation, seeking and relapse to ethanol self-administration. Addict. Biol., 2017 (Epub ahead of print: https://www.ncbi.nlm.nih.gov/pubmed/28557352).
20. Mariani, J.J., Brooks, D., Haney, M., Levin, F.R., Quantification and comparison of marijuana smoking practices: blunts joints, and pipes. Drug Alcohol Depend. 113 (2011), 249–251.
21. McClure, E.A., Baker, N.L., Gray, K.M., Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents. Am. J. Drug Alcohol Abuse 40 (2014), 285–291.
22. McClure, E.A., Gipson, C.D., Malcolm, R.J., Kalivas, P.W., Gray, K.M., Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs 28 (2014), 95–106.
23. McClure, E.A., Sonne, S.C., Winhusen, T., Carroll, K.M., Ghitza, U.E., McRae-Clark, A.L., Matthews, A.G., Sharma, G., Van Veldhuisen, P., Vandrey, R.G., Levin, F.R., Weiss, R.D., Lindblad, R., Allen, C., Mooney, L.J., Haynes, L., Brigham, G.S., Sparenborg, S., Hasson, A.L., Gray, K.M., Achieving cannabis cessation – evaluating N-acetylcysteine treatment (ACCENT) Design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network. Contemp. Clin. Trials Commun. 39 (2014), 211–223.
24. Quintanilla, M.E., Rivera-Meza, M., Berríos-Cárcamo, P., Salinas-Luypaert, C., Herrera-Marschitz, M., Israel, Y., Beyond the First Hit: marked inhibition by N-acetyl cysteine of chronic ethanol intake but not of early ethanol intake. Parallel effects on ethanol-induced saccharin motivation. Alcohol. Clin. Exp. Res. 40 (2016), 1044–1051.
25. Rhodes, K., Braakhuis, A., Performance and side effects of supplementation with N-acetylcysteine: a systematic review and meta-analysis. Sports Med. 47 (2017), 1619–1636, 10.1007/s40279-017-0677-3.
26. Roberts-Wolfe, D.J., Kalivas, P.W., Glutamate transporter GLT-1 as a therapeutic target for substance use disorders. CNS Neurol. Disord. Drug Targets 14 (2015), 745–756.
27. Schaub, M., Gmel, G., Annaheim, B., Mueller, M., Schwappach, D., Leisure time activities that predict initiation, progression and reduction of cannabis use A prospective, population-based panel survey. Drug Alcohol Rev. 29 (2010), 378–384.
28. Schneider, R.J., Santos, C.F., Clarimundo, V., Dalmaz, C., Elisabetsky, E., Gomez, R., N-acetylcysteine prevents behavioral and biochemical changes induced by alcohol cessation in rats. Alcohol 49 (2015), 259–263.
29. Sheehan, D.V., Lecrubier, Y., Harnett-Sheehan, K., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Dunbar, G., The Mini-International Neuropsychiatric Interview (M.I:N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59 (1998), S22–S33.
30. Sheehan, D.V., Sheehan, K.H., Shytle, R.D., Janavs, J., Bannon, Y., Rogers, J.E., Milo, K.M., Stock, S.L., Wilkinson, B., Reliability and validity of the mini international neuropsychiatric interview for children and adolescents (MINI-KID). J. Clin. Psychiatry 71 (2010), 313–326.
31. Sobell, L.C., Sobell, M.B., Timeline follow-back: a technique for assessing self-reported ethanol consumption. Allen, J., Litten, R.Z., (eds.) Measuring Alcohol Consumption: Psychosocial and Biological Methods, 1992, Humana Press, Totowa, NJ, 41–72.
32. Spencer, S., Kalivas, P.W., Glutamate transport: a new bench to bedside mechanism for treating drug abuse. Int. J. Neuropsychopharmacol. 20 (2017), 797–812.
33. Squeglia, L.M., Baker, N.L., McClure, E.A., Tomko, R.L., Adisetiyo, V., Gray, K.M., Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. Addict. Behav. 63 (2016), 172–177.
34. Van Schooten, F.J., Besaratinia, A., De Flora, S., D'Agostini, F., Izzotti, A., Camoirano, A., Balm, A.J., Dallinga, J.W., Bast, A., Haenen, G.R., Van't Veer, L., Baas, P., Sakai, H., Van Zandwijk, N., Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. Cancer Epidemiol. Biomarkers Prev. 11 (2002), 167–175.